Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-07-27
2002-08-27
Solola, T. A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06441201
ABSTRACT:
The present invention relates to a novel process for the preparation of 5-cyanophthalide which is an intermediate used for the manufacture of the well known antidepressant drug citalopram, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran-carbonitrile.
BACKGROUND OF THE INVENTION
Citalopram is a well known antidepressant drug that has now been on the market for some years and has the following structure:
It is a selective, centrally active serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor, accordingly having antidepressant activities. The antidepressant activity of the compound has been reported in several publications, eg. J. Hyttel,
Prog. Neuro
-
Psychopharmacol.
&
Biol. Psychiat.,
1982, 6, 277-295 and A. Gravem,
Acta Psychiatr. Scand.,
1987, 75, 478-486.
Citalopram may be prepared by the process described in U.S. Pat. No. 4,650,884, according to which 5-cyanophthalide is subjected to two successive Grignard reactions, i.e. with 4-fluorophenyl magnesium halogenide and N,N-dimethylaminopropyl magnesium halogenide, respectively, and the resulting compound of the formula
is subjected to a ring closure reaction by dehydration with strong acid.
Enantiomers of citalopram may be prepared by the method described in U.S. Pat. No. 4,943,590, i.e. by separating the enantiomers of the intermediate of Formula II and performing enantioselective ring closure in order to obtain the desired enantiomer.
Thus, 5-cyanophthalide is an important intermediate for the manufacture of citalopram and it is important to produce this material in an adequate quality, by a convenient process and in a cost-effective way.
A method for the preparation of 5-cyanophthalide has previously been described in
Bull. Soc. Sci. Bretagne,
1951, 26, 35 and in Levy and Stephen,
J. Chem. Soc.,
1931, 867. By this method, 5-aminophthalide is converted to the corresponding 5-cyanophthalide by diazotation followed by reaction with CuCN. 5-Aminophthalide was obtained from 4-aminophthalimide by a two step reduction procedure.
Synthesis of certain alkyl- and phenylnitriles from acid chlorides is described in
Tetrahedron Letters,
1982, 23, 14, 1505-1508, and in
Tetrahedron,
1998, 54, 9281.
Though a number of other methods failed, it has now been found that 5-cyanophthalide may be prepared in high yields by a convenient, cost-effective one-pot procedure from 5-carboxyphthalide.
DESCRIPTION OF THE INVENTION
Accordingly, the present invention provides a novel method for the preparation of 5-cyanophthalide
comprising reaction of 5-carboxyphthalide
with a dehydrating agent and a sulfonamide of the formula H
2
N-SO
2
-R (Formula V) wherein R is
a) NH
2
, C
1-6
alkyloxy, phenyloxy,
b) phenyloxy substituted with halogen, C
1-4
-alkyl, cyano, hydroxy, C
1-4
-alkoxy, trifluoromethyl, nitro, amino, C
1-4
-alkylamino or di-C
1-4
-alkylamino, or
c) phenyl substituted with one or more electron withdrawing substituents in order to obtain 5-cyanophthalide.
Any suitable dehydrating agent may be used and the optimal agent may easily be determined by a person skilled in the art. Examples of suitable dehydrating agents are SOCl
2
, POCl
3
, PCl
5
, SOBr
2
, POBr
3
, PBr
5
, SOI
2
, POI
3
, PI
5
and oxalylchloride. Preferably a chloro-containing agent, most preferably SOCl
2
, is used.
The term electron withdrawing substituent is intended to mean any substituent that is sufficiently electron withdrawing to allow the reaction to proceed, such as nitro, cyano, halogen, trifluoromethyl or aminosulfonyl. 3,5-Dinitrophenyl is an example of such a phenyl group substituted with electron withdrawing substituents.
In the method of the invention, the 5-carboxyphthalide reacts with the dehydration agent in order to form the corresponding 5-haloformyl derivative which then reacts with the sulfonamide of the formula V thereby forming the 5-cyanophthalide. During the latter reaction, a catalytic amount of an acid may be necessary. The 5-haloformyl derivative may, if desired, be isolated prior to further reaction. However, preferably the reaction is carried out as a one-pot procedure without isolation of the 5-haloformyl intermediate. Preferably the reaction proceeds via the 5-chloroformylphthalide.
The sulfonamide of Formula V used in the process is preferably sulfamide, i.e. a compound of Formula V wherein R is NH
2
.
The reaction is carried out neat or in a suitable solvent, such as sulfolane or acetonitrile. Preferably, sulfolane is used as the solvent.
Thus, in a preferred embodiment of the invention, 5-carboxyphthalide is reacted with sulfamide in the presence of SOCl
2
in a sulfolane solution
The reaction is carried out at elevated temperature. When sulfolane is used as the solvent, the reaction is preferably carried out at about 120-150° C.
5-Cyanophthalide may be isolated in a conventional way, e.g. by addition of water, filtration and subsequent washing of the crystals. Further purification may if desired be performed by recrystallisation.
Conveniently, 1.0 to 2.0 equivalents of sulfamide and dehydrating agent, respectively, are reacted with 1.0 equivalent 5-carboxyphthalide. Preferably, 1.0-1.2 equivalent sulfamide is used.
By the process of the invention, 5-cyanophthalide is obtained in high yields (>about 70%). The process is much more convenient than the known process and uses more convenient and cheaper reactants and conditions. Furthermore, due to the fact that the process is a one-pot procedure the capacity is substantially increased and accordingly the costs are substantially reduced.
The 5-carboxyphthalide used as a starting material may be obtained by the methods described in U.S. Pat. No. 3,607,884 or German patent No. 2630927, i.e. by reacting a concentrated solution of terephthalic acid with formaldehyde in liquid SO
3
or by electrochemical hydrogenation of trimellithic acid.
REFERENCES:
patent: 3467675 (1969-09-01), Petersen et al.
patent: 4136193 (1979-01-01), Bogeso et al.
patent: 4650884 (1987-03-01), Bogeso
patent: 4943590 (1990-07-01), Boegesoe et al.
patent: 5296507 (1994-03-01), Tanaka et al.
patent: 6020501 (2000-02-01), Massonne et al.
patent: 6028204 (2000-02-01), Massonne et al.
patent: 6229026 (2001-05-01), Petersen
patent: 6258842 (2001-07-01), Petersen et al.
patent: 6291689 (2001-09-01), Petersen et al.
patent: 2001/0027256 (2001-10-01), Petersen et al.
patent: 2002/0004604 (2002-01-01), Petersen et al.
patent: 2002/0019546 (2002-02-01), Petersen et al.
patent: 2002/0025982 (2002-02-01), Petersen et al.
patent: 2002/0026062 (2002-02-01), Petersen et al.
patent: WO 00/39112 (2000-06-01), None
patent: 1 095 926 (2001-05-01), None
patent: 9819511 (1998-05-01), None
patent: 98/19512 (1998-05-01), None
patent: 9819513 (1998-05-01), None
patent: 99/30548 (1999-06-01), None
patent: 00/11926 (2000-03-01), None
patent: 00/12044 (2000-03-01), None
patent: 00/13648 (2000-03-01), None
patent: 00/23431 (2000-04-01), None
patent: 01/45483 (2001-06-01), None
patent: 01/47877 (2001-07-01), None
patent: 01/66536 (2001-09-01), None
U.S. patent application Ser. No. 09/830,109, filed Oct. 19, 1999 (International filing date).
U.S. patent application Ser. No. 09/891,874, filed Jun. 25, 2001.
U.S. patent application Ser. No. 09/692,653, filed Oct. 19, 2000.
U.S. patent application Ser. No. 09/977,920, filed Oct. 15, 2001.
U.S. patent application Ser. No. 10/012,054, filed Nov. 6, 2001.
U.S. patent application Ser. No. 10/012,025, filed Nov. 6, 2001.
U.S. patent application Ser. No. 10/035,005, filed Dec. 20, 2001.
U.S. patent application Ser. No. 10/046,126, filed Jan. 8, 2002.
Bigler, Allan et al., “Quantitative Structure-activity Relationships in a Series of Selective 5-HT uptake inhibitors,”Eur. J. Med. Chem.3:289-295 (1997).
Forney L., “Reaction of Terephthalic Acid with Formaldehyde in Sulfur Trioxide Media,”J. Org. Chem.35:1695-1696 (1970).
Dordor et al., “Reaction of Oxazolines with Phosphorus Oxychloride,”Tetrahedron Letters24:1437-1440 (1983).
Barton et al.,Comprehensive Organic Chemistry. The Synthesis and Reactions of Organic Compounds, vol. 2, pp. 1024-1025.
Huber et
Darby & Darby
H. Lundbeck A/S
Murray Joseph
Solola T. A.
LandOfFree
Method for the preparation of 5-cyanophthalide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the preparation of 5-cyanophthalide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the preparation of 5-cyanophthalide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2951945